BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33691754)

  • 1. Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction.
    Huang C; Li G; Wu J; Liang J; Wang X
    Genome Biol; 2021 Mar; 22(1):80. PubMed ID: 33691754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants.
    Sánchez-Rivera FJ; Diaz BJ; Kastenhuber ER; Schmidt H; Katti A; Kennedy M; Tem V; Ho YJ; Leibold J; Paffenholz SV; Barriga FM; Chu K; Goswami S; Wuest AN; Simon JM; Tsanov KM; Chakravarty D; Zhang H; Leslie CS; Lowe SW; Dow LE
    Nat Biotechnol; 2022 Jun; 40(6):862-873. PubMed ID: 35165384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9-Mediated Cytosine Base Editing Screen for the Functional Assessment of
    Xiong Y; Xi X; Xiang Y; Li S; Liu H; Su Y; He R; Xiong C; Xu B; Wang X; Fu L; Zhao C; Han X; Li X; Xie S; Ruan J
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
    Tran MTN; Khalid MKNM; Pébay A; Cook AL; Liang HH; Wong RCB; Craig JE; Liu GS; Hung SS; Hewitt AW
    Mol Vis; 2019; 25():174-182. PubMed ID: 30996586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massively parallel assessment of human variants with base editor screens.
    Hanna RE; Hegde M; Fagre CR; DeWeirdt PC; Sangree AK; Szegletes Z; Griffith A; Feeley MN; Sanson KR; Baidi Y; Koblan LW; Liu DR; Neal JT; Doench JG
    Cell; 2021 Feb; 184(4):1064-1080.e20. PubMed ID: 33606977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants.
    Kweon J; Jang AH; Shin HR; See JE; Lee W; Lee JW; Chang S; Kim K; Kim Y
    Oncogene; 2020 Jan; 39(1):30-35. PubMed ID: 31467430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
    Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
    Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.
    Park JS; Nam EJ; Park HS; Han JW; Lee JY; Kim J; Kim TI; Lee ST
    Cancer Res Treat; 2017 Oct; 49(4):1012-1021. PubMed ID: 28111427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing.
    Tsai HH; Kao HJ; Kuo MW; Lin CH; Chang CM; Chen YY; Chen HH; Kwok PY; Yu AL; Yu J
    Nat Commun; 2023 Aug; 14(1):5183. PubMed ID: 37626063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminated sgRNAs-Based SurroGate System Greatly Enhances the Screening Efficiency of Plant Base-Edited Cells.
    Xu W; Yang Y; Liu Y; Kang G; Wang F; Li L; Lv X; Zhao S; Yuan S; Song J; Wu Y; Feng F; He X; Zhang C; Song W; Zhao J; Yang J
    Mol Plant; 2020 Jan; 13(1):169-180. PubMed ID: 31634585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors.
    See JE; Shin HR; Jang G; Kweon J; Kim Y
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.
    Wan Q; Hu L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
    Fam Cancer; 2021 Apr; 20(2):85-95. PubMed ID: 32803532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing.
    Liang G; Zhang H; Lou D; Yu D
    Sci Rep; 2016 Feb; 6():21451. PubMed ID: 26891616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex nucleotide editing by high-fidelity Cas9 variants with improved efficiency in rice.
    Xu W; Song W; Yang Y; Wu Y; Lv X; Yuan S; Liu Y; Yang J
    BMC Plant Biol; 2019 Nov; 19(1):511. PubMed ID: 31752697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice.
    van der Weyden L; Jonkers J; Adams DJ
    Curr Opin Genet Dev; 2021 Feb; 66():57-62. PubMed ID: 33429291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Marker-Free Precision Genome Editing and Genetic Variation through the Capture of Genomic Signatures.
    Billon P; Nambiar TS; Hayward SB; Zafra MP; Schatoff EM; Oshima K; Dunbar A; Breinig M; Park YC; Ryu HS; Tschaharganeh DF; Levine RL; Baer R; Ferrando A; Dow LE; Ciccia A
    Cell Rep; 2020 Mar; 30(10):3280-3295.e6. PubMed ID: 32160537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.
    Chung CH; Allen AG; Sullivan NT; Atkins A; Nonnemacher MR; Wigdahl B; Dampier W
    Mol Ther; 2020 Jan; 28(1):19-28. PubMed ID: 31672284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.